Cys-LC-LL-37 is a cysteine-modified variant of the human cathelicidin peptide LL-37, used to investigate redox-sensitive structural changes. Its amphipathic architecture supports studies of membrane interaction and peptide-lipid assembly. Researchers examine its conformational dynamics to understand innate immune peptide function. The molecule also aids analysis of disulfide-dependent modulation.
CAT No: L07004
1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More